Monitor AUA meeting presentations on May 16 for any clinical data readouts that could influence adoption sentiment. The PSMA PET integration initiative is exploratory with no timeline, no near-term revenue impact expected.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 15 $6.97entry
- T+1 · 6mo ago −1.15%α −1.09% · $6.89
- T+5 · 6mo ago −2.01%α −2.97% · $6.83
- T+20 · 5mo ago −3.73%α −5.85% · $6.71
- T+60 · 3mo ago +0.14%α −4.37% · $6.98
Price Chart
How similar events traded
Executive Summary
Profound Medical issued a press release announcing that its TULSA Procedure will be featured in four oral presentations at the AUA Annual Meeting on May 16, 2026, and that it is launching an initiative to explore integrating PSMA PET molecular imaging with TULSA-PRO for ablation planning. This is a routine conference-related disclosure with no financial data or material operational changes.
Key Facts
- TULSA Procedure to be highlighted in four oral presentations at AUA Annual Meeting on May 16, 2026
- Profound launching initiative to explore integration of PSMA PET molecular imaging with TULSA-PRO treatment planning software
- No financial results, guidance, or material agreements disclosed
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- PSMA PET integration initiative is exploratory with no guaranteed commercial availability
- TULSA-PRO compatibility with 0.55T MRI (Siemens Free.Max) not commercially available in all markets, including the US
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-003441 |
| Exhibit: exh_991.htm | 0001171843-26-003441 |
| Document: 0001171843-26-003441-index-headers.html | 0001171843-26-003441 |
| Document: 0001171843-26-003441-index.html | 0001171843-26-003441 |
| Document: 0001171843-26-003441.txt | 0001171843-26-003441 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers